VLP Therapeutics
MD - GaithersburgBiotechnology
Focus: VLP Therapeutics is a biotechnology company specializing in virus-like particle (VLP) vaccine platforms for infectious diseases and oncology. The company is early-stage with a minimal footprint and highly focused pipeline.
Profile data last refreshed 4h ago · AI intelligence enriched 1w ago
Open Jobs
1
Should You Work at VLP Therapeutics?
AI assessmentHigh-risk, high-reward early-stage play suitable only for scientists comfortable with venture-stage uncertainty and seeking deep technical contribution over stability.
Why Work Here
- Opportunity to contribute to novel VLP vaccine technology with applications in both infectious disease (malaria) and immuno-oncology (head/neck cancer).
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
5 microgram VLPM01
Malaria,FalciparumClinical Trials (1)
NCT03867331To Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve Volunteers
Phase 1Help build intelligence for VLP Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.